{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:45:54Z","timestamp":1793295954295,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.antiviral.2011.02.012","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T19:16:02Z","timestamp":1299525362000},"page":"70-79","source":"Crossref","is-referenced-by-count":95,"title":["Evaluation of Lassa antiviral compound ST-193 in a guinea pig model"],"prefix":"10.1016","volume":"90","author":[{"given":"Kathleen A.","family":"Cashman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A.","family":"Twenhafel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan A.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin F.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Robert D.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongcheng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarasvech","family":"Chinsangaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove\u2019 C.","family":"Bolken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis E.","family":"Hruby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Amberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E.","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary C.","family":"Guttieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2011.02.012_bib0005","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1128\/JVI.02779-06","article-title":"Bitopic membrane topology of the stable signal peptide in the tripartite Jun\u00edn virus GP-C envelope glycoprotein complex","volume":"81","author":"Agnihothram","year":"2007","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.antiviral.2011.02.012_bib0010","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.10.19145-en","article-title":"The first case of Lassa fever imported from Mali to the United Kingdom, February 2009","volume":"14","author":"Atkin","year":"2009","journal-title":"Euro Surveill."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0015","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1128\/JVI.01948-08","article-title":"Early and strong immune responses are associated with control of viral replication and recovery in Lassa virus-infected cynomolgus monkeys","volume":"83","author":"Baize","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.qai.0000174649.51084.46","article-title":"Risk factors for symptomatic mitochondrial toxicity in HIV\/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy","volume":"40","author":"Bani-Sadr","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/15303660160025903","article-title":"Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations","volume":"1","author":"Bausch","year":"2001","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0030","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1128\/JVI.66.12.7270-7281.1992","article-title":"Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus","volume":"66","author":"Borrow","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.virol.2005.12.001","article-title":"A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins","volume":"345","author":"Bredenbeek","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.02.012_bib0040","series-title":"Fields Virology","first-page":"1792","article-title":"Arenaviridae: the viruses and their replication","author":"Buchmeier","year":"2007"},{"key":"10.1016\/j.antiviral.2011.02.012_bib0045","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/0042-6822(91)90991-J","article-title":"Protein-protein interactions in lymphocytic choriomeningitis virus","volume":"183","author":"Burns","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.02.012_bib0050","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1128\/JVI.02876-06","article-title":"Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues","volume":"81","author":"Carrion","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0055","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1016\/j.vaccine.2007.02.038","article-title":"A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity","volume":"25","author":"Carrion","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2011.02.012_bib0060","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrm1076","article-title":"The structural biology of type I viral membrane fusion","volume":"4","author":"Colman","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0065","first-page":"83","article-title":"Rats, fever and sudden deafness in Sierra Leone","volume":"22","author":"Cummins","year":"1992","journal-title":"Trop. Doct."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0070","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/jama.264.16.2093","article-title":"Acute sensorineural deafness in Lassa fever","volume":"264","author":"Cummins","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2011.02.012_bib0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/viro.1995.1225","article-title":"Kinetics and pH dependence of acid-induced structural changes in the lymphocytic choriomeningitis virus glycoprotein complex","volume":"209","author":"Di Simone","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.02.012_bib0080","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1179\/joc.2008.20.5.648","article-title":"Bone marrow toxicity in HCV genotype 5a-infected patient after peg-IFN alpha-2a and ribavirin therapy","volume":"20","author":"Drapeau","year":"2008","journal-title":"J. Chemother."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0085","series-title":"Tropical Infectious Diseases: Principles, Pathogens & Practice","first-page":"734","article-title":"Arenavirus infections","author":"Enria","year":"2006"},{"key":"10.1016\/j.antiviral.2011.02.012_bib0090","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1128\/JVI.00008-06","article-title":"Identification of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2 permits assignment to class I viral fusion proteins","volume":"80","author":"Eschli","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/14760584.3.2.189","article-title":"Lassa fever vaccine","volume":"3","author":"Fisher-Hoch","year":"2004","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2011.02.012_bib0100","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/bmj.311.7009.857","article-title":"Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice","volume":"311","author":"Fisher-Hoch","year":"1995","journal-title":"BMJ"},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2011.02.012_bib0105","doi-asserted-by":"crossref","first-page":"S783","DOI":"10.1093\/clinids\/11.Supplement_4.S783","article-title":"Clinical features of Lassa fever in Liberia","volume":"11","author":"Frame","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0110","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4269\/ajtmh.1970.19.670","article-title":"Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings","volume":"19","author":"Frame","year":"1970","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0115","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/135965350501000710","article-title":"Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-\u03b12a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy","volume":"10","author":"Fuster","year":"2005","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2180-1-1","article-title":"The viral transmembrane superfamily: possible divergence of Arenavirus and Filovirus glycoproteins from a common RNA virus ancestor","volume":"1","author":"Gallaher","year":"2001","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0125","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"Geisbert","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.antiviral.2007.10.002","article-title":"Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses","volume":"78","author":"Gowen","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0135","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/AAC.00356-07","article-title":"In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections","volume":"51","author":"Gowen","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0140","doi-asserted-by":"crossref","first-page":"e3725","DOI":"10.1371\/journal.pone.0003725","article-title":"Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin","volume":"3","author":"Gowen","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2011.02.012_bib0145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/viro.1998.9586","article-title":"DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against Seoul virus infection","volume":"255","author":"Hooper","year":"1999","journal-title":"Virology"},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2011.02.012_bib0150","doi-asserted-by":"crossref","first-page":"S750","DOI":"10.1093\/clinids\/11.Supplement_4.S750","article-title":"Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug","volume":"11","author":"Huggins","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0155","unstructured":"Imported Lassa fever\u2014New Jersey, 2004. MMWR Morb. Mortal. Wkly Rep. 53, 894\u2013897."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0160","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1086\/322620","article-title":"Viral hemorrhagic fever hazards for travelers in Africa","volume":"33","author":"Isa\u00e4cson","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jmv.1890120203","article-title":"Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin","volume":"12","author":"Jahrling","year":"1983","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0170","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02122441","article-title":"Serology and virulence diversity among Old-World arenaviruses, and the relevance to vaccine development","volume":"175","author":"Jahrling","year":"1986","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0175","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/infdis\/141.5.580","article-title":"Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin","volume":"141","author":"Jahrling","year":"1980","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0180","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1128\/IAI.37.2.771-778.1982","article-title":"Pathogenesis of Lassa virus infection in guinea pigs","volume":"37","author":"Jahrling","year":"1982","journal-title":"Infect. Immun."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0185","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/infdis\/149.3.420","article-title":"Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys","volume":"149","author":"Jahrling","year":"1984","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0190","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/infdis\/155.3.456","article-title":"Clinical virology of Lassa fever in hospitalized patients","volume":"155","author":"Johnson","year":"1987","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0195","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/AAC.29.3.521","article-title":"Effect of ribavirin and tributylribavirin on Argentine hemorrhagic fever (Junin virus) in guinea pigs","volume":"29","author":"Kenyon","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.antiviral.2011.02.012_bib0200","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.06.19117-en","article-title":"A fatal case of Lassa fever in London, January 2009","volume":"14","author":"Kitching","year":"2009","journal-title":"Euro Surveill."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0205","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1111\/j.1572-0241.2002.05999.x","article-title":"Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C","volume":"97","author":"Kumar","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0210","doi-asserted-by":"crossref","first-page":"10768","DOI":"10.1128\/JVI.00941-08","article-title":"Identification of a broad-spectrum arenavirus entry inhibitor","volume":"82","author":"Larson","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0215","unstructured":"Lassa Fever Imported to England, 2000a. Commun. Dis. Rep. CDR Wkly 10, 99."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0220","unstructured":"Lassa Fever, 2000b. Case Imported to Germany. Wkly Epidemiol. Rec. 75, 17\u201318."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0225","unstructured":"Lassa Fever, 2000c. Imported Case, Netherlands. Wkly Epidemiol. Rec. 75, 265."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0230","doi-asserted-by":"crossref","first-page":"18734","DOI":"10.1074\/jbc.M802089200","article-title":"Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses","volume":"283","author":"Lee","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0235","doi-asserted-by":"crossref","first-page":"12701","DOI":"10.1073\/pnas.221447598","article-title":"The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1\/S1P","volume":"98","author":"Lenz","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2011.02.012_bib0240","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/019459989210600303","article-title":"Audiometric comparison of Lassa fever hearing loss and idiopathic sudden hearing loss: evidence for viral cause","volume":"106","author":"Liao","year":"1992","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0245","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1515\/CCLM.2006.054","article-title":"Influence of hemolysis on routine clinical chemistry testing","volume":"44","author":"Lippi","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0250","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0166-3542(89)90055-7","article-title":"Arenavirus infection in the guinea pig model: antiviral therapy with recombinant interferon-alpha, the immunomodulator CL246,738 and ribavirin","volume":"12","author":"Lucia","year":"1989","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0255","doi-asserted-by":"crossref","first-page":"13934","DOI":"10.1128\/JVI.79.22.13934-13942.2005","article-title":"A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses","volume":"79","author":"Lukashevich","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0260","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1293\/tox.13.207","article-title":"Spontaneous multiple focal to massive hepatic necrosis in guinea pigs","volume":"13","author":"Maeda","year":"2000","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0265","first-page":"193","article-title":"Lassa fever: the first confirmed case imported into Canada","volume":"15","author":"Mahdy","year":"1989","journal-title":"Can. Dis. Wkly Rep."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0270","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02122438","article-title":"Clinical, epidemiologic, and therapeutic aspects of Lassa fever","volume":"175","author":"McCormick","year":"1986","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0275","first-page":"69","article-title":"Epidemiology and control of Lassa fever","volume":"134","author":"McCormick","year":"1987","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0280","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever. Effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0285","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/infdis\/155.3.445","article-title":"A case-control study of the clinical diagnosis and course of Lassa fever","volume":"155","author":"McCormick","year":"1987","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0290","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/infdis\/155.3.437","article-title":"A prospective study of the epidemiology and ecology of Lassa fever","volume":"155","author":"McCormick","year":"1987","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0295","doi-asserted-by":"crossref","first-page":"780","DOI":"10.4269\/ajtmh.1973.22.780","article-title":"Clinical presentation of Lassa fever cases during the hospital epidemic at Zorzor, Liberia, March-April 1972","volume":"22","author":"Mertens","year":"1973","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0300","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1177\/135965350701200805","article-title":"Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients","volume":"12","author":"Mira","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0305","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.4269\/ajtmh.1974.23.1140","article-title":"Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases","volume":"23","author":"Monath","year":"1974","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0310","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1128\/AAC.01368-06","article-title":"Broad-spectrum antiviral activity of small interfering RNA targeting the conserved RNA termini of Lassa virus","volume":"51","author":"M\u00fcller","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0315","first-page":"5","article-title":"Experimental studies of arenaviral hemorrhagic fevers","volume":"134","author":"Peters","year":"1987","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0320","first-page":"127","article-title":"Haemolysis as an interference factor in clinical chemistry","volume":"24","author":"Sonntag","year":"1986","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0325","series-title":"Ribavirin: A Broad Spectrum Antiviral Agent","first-page":"169","article-title":"Ribavirin treatment of toga-, arena- and bunyavirus infections in subhuman primates and other laboratory animal species","author":"Stephen","year":"1980"},{"key":"10.1016\/j.antiviral.2011.02.012_bib0330","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jmv.1890220110","article-title":"Standardization of a plaque assay for Lassa virus","volume":"22","author":"Tomori","year":"1987","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0335","first-page":"523","article-title":"Comparative pathology of Lassa virus infection in monkeys, guinea-pigs, and Mastomys natalensis","volume":"52","author":"Walker","year":"1975","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.antiviral.2011.02.012_bib0340","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0042-6822(90)90471-3","article-title":"Post-translational processing of the glycoproteins of lymphocytic choriomeningitis virus","volume":"177","author":"Wright","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.02.012_bib0345","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.virol.2005.08.030","article-title":"Genetic analysis of heptad-repeat regions in the G2 fusion subunit of the Jun\u00edn arenavirus envelope glycoprotein","volume":"343","author":"York","year":"2005","journal-title":"Virology"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211000507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211000507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T16:29:43Z","timestamp":1685982583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354211000507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0166354211000507"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2011.02.012","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}